Selected research
Industry Research
Fluoxetine Industry Research Report 2026
Market perspective
The global Fluoxetine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Fluoxetine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Fluoxetine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Fluoxetine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Fluoxetine include Teva, Sun Pharmaceutical, Suzhou YUSHI Pharmaceutical, Sandoz, Mylan, Changzhou Siyao Pharmaceutical, Wockhardt, Torrent Pharmaceuticals and Pharmaceutical Associates Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Fluoxetine market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Fluoxetine Market by Company
Teva
Sun Pharmaceutical
Suzhou YUSHI Pharmaceutical
Sandoz
Mylan
Changzhou Siyao Pharmaceutical
Wockhardt
Torrent Pharmaceuticals
Pharmaceutical Associates Inc.
Lannett Company
Dr.Reddy's Laboratories
Aurobindo Pharma
Alvogen
Alembic Pharmaceuticals
Fluoxetine Segment by Type
Capsules
Oral Solution
Tablets
Fluoxetine Segment by Application
Depression
Bulimia Nervosa
Obsessive–Compulsive Disorder
Panic Disorder
Others
Fluoxetine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fluoxetine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Fluoxetine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fluoxetine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Fluoxetine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Fluoxetine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Fluoxetine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Capsules
- Oral Solution
- Tablets
Applications
- Depression
- Bulimia Nervosa
- Obsessive–Compulsive Disorder
- Panic Disorder
- Others
Companies covered
- Teva
- Sun Pharmaceutical
- Suzhou YUSHI Pharmaceutical
- Sandoz
- Mylan
- Changzhou Siyao Pharmaceutical
- Wockhardt
- Torrent Pharmaceuticals
- Pharmaceutical Associates Inc.
- Lannett Company
- Dr.Reddy's Laboratories
- Aurobindo Pharma
- Alvogen
- Alembic Pharmaceuticals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Fluoxetine Market Size (2021-2032)
- 2.2.2 Global Fluoxetine Sales (2021-2032)
- 2.2.3 Global Fluoxetine Market Average Price (2021-2032)
- 2.3 Fluoxetine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Capsules
- 2.3.3 Oral Solution
- 2.3.4 Tablets
- 2.4 Fluoxetine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Depression
- 2.4.3 Bulimia Nervosa
- 2.4.4 Obsessive–Compulsive Disorder
- 2.4.5 Panic Disorder
- 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Fluoxetine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Fluoxetine Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Fluoxetine Revenue of Manufacturers (2021-2026)
- 3.4 Global Fluoxetine Average Price by Manufacturers (2021-2026)
- 3.5 Global Fluoxetine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Fluoxetine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Fluoxetine, Product Type & Application
- 3.8 Global Manufacturers of Fluoxetine, Established Date
- 3.9 Global Fluoxetine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva
- 4.1.1 Teva Company Information
- 4.1.2 Teva Business Overview
- 4.1.3 Teva Fluoxetine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Fluoxetine Product Portfolio
- 4.1.5 Teva Recent Developments
- 4.2 Sun Pharmaceutical
- 4.2.1 Sun Pharmaceutical Company Information
- 4.2.2 Sun Pharmaceutical Business Overview
- 4.2.3 Sun Pharmaceutical Fluoxetine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sun Pharmaceutical Fluoxetine Product Portfolio
- 4.2.5 Sun Pharmaceutical Recent Developments
- 4.3 Suzhou YUSHI Pharmaceutical
- 4.3.1 Suzhou YUSHI Pharmaceutical Company Information
- 4.3.2 Suzhou YUSHI Pharmaceutical Business Overview
- 4.3.3 Suzhou YUSHI Pharmaceutical Fluoxetine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Suzhou YUSHI Pharmaceutical Fluoxetine Product Portfolio
- 4.3.5 Suzhou YUSHI Pharmaceutical Recent Developments
- 4.4 Sandoz
- 4.4.1 Sandoz Company Information
- 4.4.2 Sandoz Business Overview
- 4.4.3 Sandoz Fluoxetine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Sandoz Fluoxetine Product Portfolio
- 4.4.5 Sandoz Recent Developments
- 4.5 Mylan
- 4.5.1 Mylan Company Information
- 4.5.2 Mylan Business Overview
- 4.5.3 Mylan Fluoxetine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Mylan Fluoxetine Product Portfolio
- 4.5.5 Mylan Recent Developments
- 4.6 Changzhou Siyao Pharmaceutical
- 4.6.1 Changzhou Siyao Pharmaceutical Company Information
- 4.6.2 Changzhou Siyao Pharmaceutical Business Overview
- 4.6.3 Changzhou Siyao Pharmaceutical Fluoxetine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Changzhou Siyao Pharmaceutical Fluoxetine Product Portfolio
- 4.6.5 Changzhou Siyao Pharmaceutical Recent Developments
- 4.7 Wockhardt
- 4.7.1 Wockhardt Company Information
- 4.7.2 Wockhardt Business Overview
- 4.7.3 Wockhardt Fluoxetine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Wockhardt Fluoxetine Product Portfolio
- 4.7.5 Wockhardt Recent Developments
- 4.8 Torrent Pharmaceuticals
- 4.8.1 Torrent Pharmaceuticals Company Information
- 4.8.2 Torrent Pharmaceuticals Business Overview
- 4.8.3 Torrent Pharmaceuticals Fluoxetine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Torrent Pharmaceuticals Fluoxetine Product Portfolio
- 4.8.5 Torrent Pharmaceuticals Recent Developments
- 4.9 Pharmaceutical Associates Inc.
- 4.9.1 Pharmaceutical Associates Inc. Company Information
- 4.9.2 Pharmaceutical Associates Inc. Business Overview
- 4.9.3 Pharmaceutical Associates Inc. Fluoxetine Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Pharmaceutical Associates Inc. Fluoxetine Product Portfolio
- 4.9.5 Pharmaceutical Associates Inc. Recent Developments
- 4.10 Lannett Company
- 4.10.1 Lannett Company Company Information
- 4.10.2 Lannett Company Business Overview
- 4.10.3 Lannett Company Fluoxetine Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Lannett Company Fluoxetine Product Portfolio
- 4.10.5 Lannett Company Recent Developments
- 4.11 Dr.Reddy's Laboratories
- 4.11.1 Dr.Reddy's Laboratories Company Information
- 4.11.2 Dr.Reddy's Laboratories Business Overview
- 4.11.3 Dr.Reddy's Laboratories Fluoxetine Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Dr.Reddy's Laboratories Fluoxetine Product Portfolio
- 4.11.5 Dr.Reddy's Laboratories Recent Developments
- 4.12 Aurobindo Pharma
- 4.12.1 Aurobindo Pharma Company Information
- 4.12.2 Aurobindo Pharma Business Overview
- 4.12.3 Aurobindo Pharma Fluoxetine Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Aurobindo Pharma Fluoxetine Product Portfolio
- 4.12.5 Aurobindo Pharma Recent Developments
- 4.13 Alvogen
- 4.13.1 Alvogen Company Information
- 4.13.2 Alvogen Business Overview
- 4.13.3 Alvogen Fluoxetine Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Alvogen Fluoxetine Product Portfolio
- 4.13.5 Alvogen Recent Developments
- 4.14 Alembic Pharmaceuticals
- 4.14.1 Alembic Pharmaceuticals Company Information
- 4.14.2 Alembic Pharmaceuticals Business Overview
- 4.14.3 Alembic Pharmaceuticals Fluoxetine Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Alembic Pharmaceuticals Fluoxetine Product Portfolio
- 4.14.5 Alembic Pharmaceuticals Recent Developments
5 Global Fluoxetine Market Scenario by Region
- 5.1 Global Fluoxetine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Fluoxetine Sales by Region: 2021-2032
- 5.2.1 Global Fluoxetine Sales by Region: 2021-2026
- 5.2.2 Global Fluoxetine Sales by Region: 2027-2032
- 5.3 Global Fluoxetine Revenue by Region: 2021-2032
- 5.3.1 Global Fluoxetine Revenue by Region: 2021-2026
- 5.3.2 Global Fluoxetine Revenue by Region: 2027-2032
- 5.4 North America Fluoxetine Market Facts & Figures by Country
- 5.4.1 North America Fluoxetine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Fluoxetine Sales by Country (2021-2032)
- 5.4.3 North America Fluoxetine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Fluoxetine Market Facts & Figures by Country
- 5.5.1 Europe Fluoxetine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Fluoxetine Sales by Country (2021-2032)
- 5.5.3 Europe Fluoxetine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Fluoxetine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Fluoxetine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Fluoxetine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Fluoxetine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Fluoxetine Market Facts & Figures by Country
- 5.7.1 South America Fluoxetine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Fluoxetine Sales by Country (2021-2032)
- 5.7.3 South America Fluoxetine Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Fluoxetine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Fluoxetine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Fluoxetine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Fluoxetine Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Fluoxetine Sales by Type (2021-2032)
- 6.1.1 Global Fluoxetine Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Fluoxetine Sales Market Share by Type (2021-2032)
- 6.2 Global Fluoxetine Revenue by Type (2021-2032)
- 6.2.1 Global Fluoxetine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Fluoxetine Revenue Market Share by Type (2021-2032)
- 6.3 Global Fluoxetine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Fluoxetine Sales by Application (2021-2032)
- 7.1.1 Global Fluoxetine Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Fluoxetine Sales Market Share by Application (2021-2032)
- 7.2 Global Fluoxetine Revenue by Application (2021-2032)
- 7.2.1 Global Fluoxetine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Fluoxetine Revenue Market Share by Application (2021-2032)
- 7.3 Global Fluoxetine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Fluoxetine Value Chain Analysis
- 8.1.1 Fluoxetine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Fluoxetine Production Mode & Process
- 8.2 Fluoxetine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Fluoxetine Distributors
- 8.2.3 Fluoxetine Customers
9 Global Fluoxetine Analyzing Market Dynamics
- 9.1 Fluoxetine Industry Trends
- 9.2 Fluoxetine Industry Drivers
- 9.3 Fluoxetine Industry Opportunities and Challenges
- 9.4 Fluoxetine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst